BIOX vs. FULC

Last updated Apr 2, 2026

Compare and contrast key facts about Bioceres Crop Solutions Corp. (BIOX) and Fulcrum Therapeutics, Inc. (FULC).

Performance

BIOX vs. FULC - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Bioceres Crop Solutions Corp. (BIOX) and Fulcrum Therapeutics, Inc. (FULC). The values are adjusted to include any dividend payments, if applicable.

BIOX vs. FULC - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019
BIOX Bioceres Crop Solutions Corp.	-63.74%	-78.45%	-55.72%	14.13%	-14.92%	128.06%	22.80%	-16.82%
FULC Fulcrum Therapeutics, Inc.	-33.86%	140.64%	-30.37%	-7.28%	-58.85%	51.07%	-29.63%	23.26%

Fundamentals

Market Cap BIOX : $30.15M FULC : $473.90M
EPS BIOX : -$3.72 FULC : -$1.19
PB Ratio BIOX : 0.41 FULC : 1.36
Total Revenue (TTM) BIOX : $285.11M FULC : $0.00
Gross Profit (TTM) BIOX : $105.70M FULC : $0.00
EBITDA (TTM) BIOX : $12.08M FULC : -$84.77M

Returns By Period

In the year-to-date period, BIOX achieves a -63.74% return, which is significantly lower than FULC's -33.86% return.

BIOX

• 1D: 6.77%
• 1M: 3.49%
• YTD: -63.74%
• 6M: -65.33%
• 1Y: -89.35%
• 3Y*: -65.54%
• 5Y*: -46.21%
• 10Y*: —

FULC

• 1D: -2.48%
• 1M: -4.23%
• YTD: -33.86%
• 6M: -19.83%
• 1Y: 171.01%
• 3Y*: 37.94%
• 5Y*: -9.02%
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

Return for Risk

BIOX vs. FULC — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

BIOX

BIOX Risk / Return Rank: 4
BIOX Sharpe Ratio Rank: 5
BIOX Sortino Ratio Rank: 1
BIOX Omega Ratio Rank: 2
BIOX Calmar Ratio Rank: 4
BIOX Martin Ratio Rank: 9

FULC

FULC Risk / Return Rank: 86
FULC Sharpe Ratio Rank: 88
FULC Sortino Ratio Rank: 90
FULC Omega Ratio Rank: 86
FULC Calmar Ratio Rank: 84
FULC Martin Ratio Rank: 83

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

BIOX vs. FULC - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Bioceres Crop Solutions Corp. (BIOX) and Fulcrum Therapeutics, Inc. (FULC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	BIOX	FULC	Difference
Sharpe ratio Return per unit of total volatility	-0.93	1.83	-2.76
Sortino ratio Return per unit of downside risk	-2.43	2.89	-5.33
Omega ratio Gain probability vs. loss probability	0.72	1.35	-0.62
Calmar ratio Return relative to maximum drawdown	-0.97	2.91	-3.87
Martin ratio Return relative to average drawdown	-1.51	7.58	-9.08
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

BIOX vs. FULC - Sharpe Ratio Comparison

The current BIOX Sharpe Ratio is -0.93, which is lower than the FULC Sharpe Ratio of 1.83. The chart below compares the historical Sharpe Ratios of BIOX and FULC, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Sharpe Ratios by Period

	BIOX	FULC	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	-0.93	1.83	-2.76
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	-0.75	-0.08	-0.67
Sharpe Ratio (All Time) Calculated using the full available price history	-0.49	-0.08	-0.42

Correlation

The correlation between BIOX and FULC is 0.15, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Dividends

BIOX vs. FULC - Dividend Comparison

Neither BIOX nor FULC has paid dividends to shareholders.

Tickers have no history of dividend payments

Drawdowns

BIOX vs. FULC - Drawdown Comparison

The maximum BIOX drawdown since its inception was -97.68%, which is greater than FULC's maximum drawdown of -92.70%. Use the drawdown chart below to compare losses from any high point for BIOX and FULC.

Drawdown Indicators

	BIOX	FULC	Difference
Max Drawdown Largest peak-to-trough decline	-97.68%	-92.70%	-4.98%
Max Drawdown (1Y) Largest decline over 1 year	-92.82%	-54.93%	-37.89%
Max Drawdown (5Y) Largest decline over 5 years	-97.68%	-92.70%	-4.98%
Current Drawdown Current decline from peak	-97.03%	-75.85%	-21.18%
Average Drawdown Average peak-to-trough decline	-34.78%	-62.28%	+27.50%
Ulcer Index Depth and duration of drawdowns from previous peaks	59.46%	21.08%	+38.38%

Volatility

BIOX vs. FULC - Volatility Comparison

Bioceres Crop Solutions Corp. (BIOX) has a higher volatility of 36.79% compared to Fulcrum Therapeutics, Inc. (FULC) at 21.01%. This indicates that BIOX's price experiences larger fluctuations and is considered to be riskier than FULC based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	BIOX	FULC	Difference
Volatility (1M) Calculated over the trailing 1-month period	36.79%	21.01%	+15.78%
Volatility (6M) Calculated over the trailing 6-month period	85.64%	68.96%	+16.68%
Volatility (1Y) Calculated over the trailing 1-year period	95.75%	94.30%	+1.45%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	61.93%	108.64%	-46.71%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	63.63%	111.22%	-47.59%

Financials